The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children
|
|---|---|
| Published in |
Cochrane database of systematic reviews, December 2011
|
| DOI | 10.1002/14651858.cd004106.pub4 |
| Pubmed ID | |
| Authors |
Toby J Lasserson, Giovanni Ferrara, Lucio Casali |
| Abstract |
Long-acting beta-agonists are a common second line treatment in people with asthma inadequately controlled with inhaled corticosteroids. Single device inhalers combine a long-acting beta-agonist with an inhaled steroid delivering both drugs as a maintenance treatment regimen. This updated review compares two fixed-dose options, fluticasone/salmeterol FP/SALand budesonide/formoterol, since this comparison represents a common therapeutic choice. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | 33% |
| Peru | 1 | 17% |
| Unknown | 3 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 83% |
| Practitioners (doctors, other healthcare professionals) | 1 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 206 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Colombia | 1 | <1% |
| Ireland | 1 | <1% |
| Unknown | 203 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 28 | 14% |
| Student > Master | 22 | 11% |
| Student > Ph. D. Student | 15 | 7% |
| Student > Bachelor | 14 | 7% |
| Other | 10 | 5% |
| Other | 35 | 17% |
| Unknown | 82 | 40% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 59 | 29% |
| Nursing and Health Professions | 23 | 11% |
| Psychology | 8 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 2% |
| Social Sciences | 4 | 2% |
| Other | 17 | 8% |
| Unknown | 90 | 44% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 May 2020.
All research outputs
#3,684,217
of 25,806,080 outputs
Outputs from Cochrane database of systematic reviews
#6,343
of 13,140 outputs
Outputs of similar age
#27,356
of 249,168 outputs
Outputs of similar age from Cochrane database of systematic reviews
#82
of 213 outputs
Altmetric has tracked 25,806,080 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,140 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 249,168 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 213 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.